OCC North America

OCC North America appears to have been a healthcare and pharmaceutical medical communications company rather than a therapeutic drug developer. Public references associate it with creating publication and communication materials for pharmaceutical clients, including work connected to Wyeth, and business-directory records show it operated in Pennsylvania and the broader U.S. Northeast. Available evidence suggests it provided medical writing, scientific communications, and related agency services to the pharmaceutical industry. I found no evidence that it operated a proprietary drug pipeline, therapeutic platform, or clinical development portfolio. The entity appears to be historical/inactive based on the age and nature of the available records and the lack of a current operating web presence.